Tamarly Intelligence
Deal · Completed

Vertex Pharmaceuticals Incorporated and Crinetics Pharmaceuticals, Inc.

First filed 1 Sept 2026, 1 filing.

The deal
Buyer
Vertex Pharmaceuticals Incorporated
Target
Crinetics Pharmaceuticals, Inc.
Status
Completed
Region
US
As previously disclosed in the Current Report on Form 8-K filed with the U.S.

Source: The filing (SEC Form 8-K)

With a free account

A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Vertex Pharmaceuticals Incorporated and Crinetics Pharmaceuticals, Inc.: deal completed (2026) | Tamarly